Neuroblastoma: Dosimetry for MIBG Therapies
Author:
Publisher
Springer Netherlands
Link
http://link.springer.com/content/pdf/10.1007/978-94-007-2418-1_18
Reference21 articles.
1. Bolster A, Hilditch TE, Wheldon TE, Gaze MN, Barrett A (1995) Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children. Br J Radiol 68:481–490
2. Buckley SE, Gaze MN, Chittenden S, Partridge M, Lancaster D, Pearson A, Flux GD (2007) Dosimetry for fractionated 131I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results. Cancer Biother Radiopharm 22:105–112
3. Buckley SE, Chittenden SJ, Saran F, Meller ST, Flux GD (2009) Whole body dosimetry for individualized treatment planning of 131IMIBG radionuclide therapy for neuroblastoma. J Nucl Med 50:1518–1524
4. DuBois SG, Messina J, Maris JM, Hunerty J, Glidden DV, Veatch J, Charron M, Hawkins R, Matthay KK (2004) Hematologic toxicity of high-dose Iodine-131-Metaiodobenzylguanidin therapy for advanced neuroblastoma. J Clin Oncol 22:2452–2460
5. Fielding SL, Flower MA, Ackery D, Kemshead JT, Lashford LS, Lewis I (1991) Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. Eur J Nucl Med 18:308–316
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3